Cargando…

COVID-19 Vaccination Acceptance in China after It Becomes Available: A Cross-Sectional Study

The outbreak of coronavirus disease 2019 (COVID-19) has led to numerous tragic deaths all over the world. Great efforts have been made by worldwide nations for COVID-19 targeted vaccine development since the disease outbreak. In January 2021, the Chinese government started to provide free vaccinatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Qian, Tian, Tian, Ni, Jie, Zhao, Xiaoheng, Li, Hong, Yang, Yili, Zhang, Yumeng, Pan, Jay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709027/
https://www.ncbi.nlm.nih.gov/pubmed/34960144
http://dx.doi.org/10.3390/vaccines9121398
_version_ 1784622832548839424
author Zhou, Qian
Tian, Tian
Ni, Jie
Zhao, Xiaoheng
Li, Hong
Yang, Yili
Zhang, Yumeng
Pan, Jay
author_facet Zhou, Qian
Tian, Tian
Ni, Jie
Zhao, Xiaoheng
Li, Hong
Yang, Yili
Zhang, Yumeng
Pan, Jay
author_sort Zhou, Qian
collection PubMed
description The outbreak of coronavirus disease 2019 (COVID-19) has led to numerous tragic deaths all over the world. Great efforts have been made by worldwide nations for COVID-19 targeted vaccine development since the disease outbreak. In January 2021, the Chinese government started to provide free vaccination among nationwide communities, which was optional for citizens. As no evidence has been provided so far regarding COVID-19 vaccination acceptance since the initiation of nationwide vaccination, this study aims to investigate COVID-19 vaccination acceptance among Chinese citizens as well as its associated factors as an attempt to bridge such gap embedded in the current literature. An anonymous cross-sectional study was conducted online in March and April 2021 among adults, with the survey questionnaire designed based on the framework of the health belief model (HBM). Information on socio-demographics, risk perception, past pandemic-related experience, awareness of vaccination as well as acceptance of COVID-19 vaccination were collected. Chi-squared test and multi-level regression were performed to distinguish the acceptance between different groups as well as to identify the significant predictors. A total of 3940 participants completed the survey, with 90.6% of the participants reporting strong willingness to get vaccinated. A list of factors were found to be significantly associated with individuals’ acceptance of vaccination, including the region of residence, ethnicity, annual income, whether or not they had experienced a major pandemic event in the past, risk perception of the COVID-19 as well as the awareness of receiving vaccination. Safety concerns about the vaccine (27.7%), concerns about receiving vaccination immediately after newly developed vaccines were released into the market (22.4%) as well as concerns about the potential side effects induced by vaccination (22.1%) were identified as the primary reasons of residents’ resistance against vaccination. Overall, residents demonstrated strong willingness to receive vaccination against COVID-19 in China. However, the improvement of vaccination-related knowledge among Chinese residents should be highlighted as a critical strategy to facilitate the penetration of nationwide vaccination in order to ultimately achieve the establishment of herd immunity in China.
format Online
Article
Text
id pubmed-8709027
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87090272021-12-25 COVID-19 Vaccination Acceptance in China after It Becomes Available: A Cross-Sectional Study Zhou, Qian Tian, Tian Ni, Jie Zhao, Xiaoheng Li, Hong Yang, Yili Zhang, Yumeng Pan, Jay Vaccines (Basel) Article The outbreak of coronavirus disease 2019 (COVID-19) has led to numerous tragic deaths all over the world. Great efforts have been made by worldwide nations for COVID-19 targeted vaccine development since the disease outbreak. In January 2021, the Chinese government started to provide free vaccination among nationwide communities, which was optional for citizens. As no evidence has been provided so far regarding COVID-19 vaccination acceptance since the initiation of nationwide vaccination, this study aims to investigate COVID-19 vaccination acceptance among Chinese citizens as well as its associated factors as an attempt to bridge such gap embedded in the current literature. An anonymous cross-sectional study was conducted online in March and April 2021 among adults, with the survey questionnaire designed based on the framework of the health belief model (HBM). Information on socio-demographics, risk perception, past pandemic-related experience, awareness of vaccination as well as acceptance of COVID-19 vaccination were collected. Chi-squared test and multi-level regression were performed to distinguish the acceptance between different groups as well as to identify the significant predictors. A total of 3940 participants completed the survey, with 90.6% of the participants reporting strong willingness to get vaccinated. A list of factors were found to be significantly associated with individuals’ acceptance of vaccination, including the region of residence, ethnicity, annual income, whether or not they had experienced a major pandemic event in the past, risk perception of the COVID-19 as well as the awareness of receiving vaccination. Safety concerns about the vaccine (27.7%), concerns about receiving vaccination immediately after newly developed vaccines were released into the market (22.4%) as well as concerns about the potential side effects induced by vaccination (22.1%) were identified as the primary reasons of residents’ resistance against vaccination. Overall, residents demonstrated strong willingness to receive vaccination against COVID-19 in China. However, the improvement of vaccination-related knowledge among Chinese residents should be highlighted as a critical strategy to facilitate the penetration of nationwide vaccination in order to ultimately achieve the establishment of herd immunity in China. MDPI 2021-11-25 /pmc/articles/PMC8709027/ /pubmed/34960144 http://dx.doi.org/10.3390/vaccines9121398 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zhou, Qian
Tian, Tian
Ni, Jie
Zhao, Xiaoheng
Li, Hong
Yang, Yili
Zhang, Yumeng
Pan, Jay
COVID-19 Vaccination Acceptance in China after It Becomes Available: A Cross-Sectional Study
title COVID-19 Vaccination Acceptance in China after It Becomes Available: A Cross-Sectional Study
title_full COVID-19 Vaccination Acceptance in China after It Becomes Available: A Cross-Sectional Study
title_fullStr COVID-19 Vaccination Acceptance in China after It Becomes Available: A Cross-Sectional Study
title_full_unstemmed COVID-19 Vaccination Acceptance in China after It Becomes Available: A Cross-Sectional Study
title_short COVID-19 Vaccination Acceptance in China after It Becomes Available: A Cross-Sectional Study
title_sort covid-19 vaccination acceptance in china after it becomes available: a cross-sectional study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709027/
https://www.ncbi.nlm.nih.gov/pubmed/34960144
http://dx.doi.org/10.3390/vaccines9121398
work_keys_str_mv AT zhouqian covid19vaccinationacceptanceinchinaafteritbecomesavailableacrosssectionalstudy
AT tiantian covid19vaccinationacceptanceinchinaafteritbecomesavailableacrosssectionalstudy
AT nijie covid19vaccinationacceptanceinchinaafteritbecomesavailableacrosssectionalstudy
AT zhaoxiaoheng covid19vaccinationacceptanceinchinaafteritbecomesavailableacrosssectionalstudy
AT lihong covid19vaccinationacceptanceinchinaafteritbecomesavailableacrosssectionalstudy
AT yangyili covid19vaccinationacceptanceinchinaafteritbecomesavailableacrosssectionalstudy
AT zhangyumeng covid19vaccinationacceptanceinchinaafteritbecomesavailableacrosssectionalstudy
AT panjay covid19vaccinationacceptanceinchinaafteritbecomesavailableacrosssectionalstudy